ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
203.00
0.28
(0.14%)
At close: April 22 4:00PM
203.00
0.28
( 0.14% )
After Hours: 5:12PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
203.00
Bid
-
Ask
-
Volume
348,314
200.80 Day's Range 206.36
180.93 52 Week Range 348.67
Market Cap
Previous Close
202.72
Open
204.04
Last Trade
39
@
205.14
Last Trade Time
16:32:47
Financial Volume
$ 70,976,693
VWAP
203.7722
Average Volume (3m)
344,667
Shares Outstanding
38,703,659
Dividend Yield
-
PE Ratio
86.36
Earnings Per Share (EPS)
2.35
Revenue
1.06B
Net Profit
90.95M

About Penumbra Inc

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurova... Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Dover, Delaware, USA
Founded
1970
Penumbra Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker PEN. The last closing price for Penumbra was $202.72. Over the last year, Penumbra shares have traded in a share price range of $ 180.93 to $ 348.67.

Penumbra currently has 38,703,659 shares outstanding. The market capitalization of Penumbra is $7.85 billion. Penumbra has a price to earnings ratio (PE ratio) of 86.36.

Penumbra (PEN) Options Flow Summary

Overall Flow

Bullish

Net Premium

54k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

PEN Latest News

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 PR Newswire ALAMEDA, Calif., April 9, 2024 ALAMEDA, Calif., April 9, 2024 /PRNewswire/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-16.24-7.40740740741219.24221.13199.38291351206.17774543CS
4-22.73-10.0695521198225.73228.76199.38344911217.19261762CS
12-48.09-19.1524951213251.09277.34199.38344667235.77202407CS
26-2.22-1.08176590976205.22277.34180.93368256229.44532567CS
52-77.68-27.6756448625280.68348.67180.93376573257.03395973CS
156-81.81-28.7244127664284.81348.67114.865309336231.0665373CS
26074.0857.461991933128.92348.67107.5359980210.25738316CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUWENewellis Inc
$ 0.4441
(32.96%)
6.64M
PEGYPineapple Energy Inc
$ 0.0559
(22.05%)
5.48M
MEGLMagic Empire Global Limited
$ 0.71
(17.74%)
1.54M
ACETAdicet Bio Inc
$ 2.35
(17.50%)
9.03k
AGBAAGBA Group Holding Ltd
$ 2.93
(17.20%)
7.59M
ABEOAbeona Therapeutics Inc
$ 3.57
(-51.49%)
407.94k
JAGXJaguar Health Inc
$ 0.1479
(-17.79%)
12.76M
ZAPPZapp Electric Vehicles Group Ltd
$ 0.184
(-17.12%)
348.94k
TTOOT2 Biosystems Inc
$ 2.79
(-11.71%)
44.35k
TCBPTC BioPharm Holdings PLC
$ 1.40
(-11.39%)
12.55k
JAGXJaguar Health Inc
$ 0.1479
(-17.79%)
12.76M
AGBAAGBA Group Holding Ltd
$ 2.93
(17.20%)
7.59M
NUWENewellis Inc
$ 0.4441
(32.96%)
6.64M
PEGYPineapple Energy Inc
$ 0.0559
(22.05%)
5.48M
CORZCore Scientific Inc
$ 3.20
(-2.14%)
4.01M

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 3 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 3 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 3 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 3 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 3 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 9 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 9 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 9 years ago
IPO should be out soon.
no symbol yet.
👍️0

Your Recent History

Delayed Upgrade Clock